UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

The Lancet (British edition), 2014-08, Vol.384 (9944), p.665-673

2014

Volltextzugriff (PDF)

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3543-3551

2008

Volltextzugriff (PDF)

Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial

Journal of clinical oncology, 2012-10, Vol.30 (29), p.3640-3647

2012

Volltextzugriff (PDF)

Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2017-10, Vol.112, p.126-133

2017

Volltextzugriff (PDF)

Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations

International journal of clinical oncology, 2015-04, Vol.20 (2), p.395-404

2015

Volltextzugriff (PDF)

High dose rate endobronchial brachytherapy in the management of lung cancer: Response and toxicity evaluation in 158 patients

Lung cancer (Amsterdam, Netherlands), 2008-12, Vol.62 (3), p.326-333

2008

Volltextzugriff (PDF)

Patient and physician delay in the diagnosis and treatment of non-small cell lung cancer in Turkey

Cancer epidemiology, 2015-04, Vol.39 (2), p.216-221

2015

Volltextzugriff (PDF)

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-09, Vol.328 (12), p.1223

2022

Volltextzugriff (PDF)

Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer

Annals of nuclear medicine, 2006-05, Vol.20 (4), p.269-275

2006

Volltextzugriff (PDF)

Successful Colchicine Therapy in a Patient With Follicular Bronchiolitis Presumed to Be Asthma

Respiratory care, 2015-07, Vol.60 (7), p.e122-e124

2015

Volltextzugriff (PDF)

The role of Tc-99m sestamibi imaging in predicting clinical response to chemotherapy in lung cancer

Annals of nuclear medicine, 2002-04, Vol.16 (2), p.103-108

2002

Volltextzugriff (PDF)

Clinical characteristics of patients with bronchioloalveolar carcinoma: a retrospective study of 44 cases

Asian Pacific journal of cancer prevention : APJCP, 2013-01, Vol.14 (7), p.4365-4368

2013

Volltextzugriff (PDF)

Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study

European journal of cancer (1990), 2009-09, Vol.45 (13), p.2298-2303

2009

Volltextzugriff (PDF)

cfDNA in exhaled breath condensate (EBC) and contamination by ambient air: toward volatile biopsies

Journal of breath research, 2019-05, Vol.13 (3), p.036006-036006

2019

Volltextzugriff (PDF)

A Randomized, Double-blind, Placebo-controlled Study to Assess QTc Interval Prolongation of Standard Dose Aflibercept in Cancer Patients Treated With Docetaxel

Journal of cardiovascular pharmacology, 2013-06, Vol.61 (6), p.495-504

2013

Volltextzugriff (PDF)

Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: A phase II study

Lung cancer (Amsterdam, Netherlands), 2007-11, Vol.58 (2), p.246-252

2007

Volltextzugriff (PDF)

Success of a Smoking Cessation Program among Smoking Relatives of Patients with Serious Smoking-Related Pulmonary Disorders

European addiction research, 2005-01, Vol.11 (2), p.57-61

2005

Volltextzugriff (PDF)

High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2001-11, Vol.34 (2), p.253-259

2001

Volltextzugriff (PDF)

Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients

Tüberküloz ve toraks, 2006, Vol.54 (2), p.161

2006

Volltextzugriff (PDF)

Pattern of Lung Cancer in Turkey, 1994–1998

Respiration, 2002, Vol.69 (3), p.207-210

2002

Volltextzugriff (PDF)

A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non-small cell lung cancer

Respirology (Carlton, Vic.), 2005-09, Vol.10 (4), p.456-463

2005

Volltextzugriff (PDF)

Smoking Habit among the Relatives of Patients with Serious Smoking-Related Disorders

European addiction research, 2002-06, Vol.8 (3), p.118-121, Article 118

2002

Volltextzugriff (PDF)

Effectiveness of gemcitabine as second-line chemotherapy in non-small cell lung cancer

Tüberküloz ve toraks, 2008, Vol.56 (1), p.74-80

2008

Volltextzugriff (PDF)

Results of surgical treatment for lung cancer in advanced age

Tüberküloz ve toraks, 2003, Vol.51 (3), p.253-257

2003

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionSAGE Journals Online

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(29)

Sprache

Englisch
(27)
Türkisch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial

Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer

Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations

High dose rate endobronchial brachytherapy in the management of lung cancer: Response and toxicity evaluation in 158 patients

Patient and physician delay in the diagnosis and treatment of non-small cell lung cancer in Turkey

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial

Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer

Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy

Successful Colchicine Therapy in a Patient With Follicular Bronchiolitis Presumed to Be Asthma

The role of Tc-99m sestamibi imaging in predicting clinical response to chemotherapy in lung cancer

Clinical characteristics of patients with bronchioloalveolar carcinoma: a retrospective study of 44 cases

Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study

cfDNA in exhaled breath condensate (EBC) and contamination by ambient air: toward volatile biopsies

A Randomized, Double-blind, Placebo-controlled Study to Assess QTc Interval Prolongation of Standard Dose Aflibercept in Cancer Patients Treated With Docetaxel

Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: A phase II study

Success of a Smoking Cessation Program among Smoking Relatives of Patients with Serious Smoking-Related Pulmonary Disorders

High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer

Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients

Pattern of Lung Cancer in Turkey, 1994–1998

A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non-small cell lung cancer

Smoking Habit among the Relatives of Patients with Serious Smoking-Related Disorders

Effectiveness of gemcitabine as second-line chemotherapy in non-small cell lung cancer

Results of surgical treatment for lung cancer in advanced age

Aktive Filter

Suchergebnisse filtern